| 0 |
OVERLAP SYNDROME |
75 |
0.1071 |
| 1 |
PRODUCT ODOUR ABNORMAL |
1055 |
0.1006 |
| 2 |
POOR QUALITY PRODUCT ADMINISTERED |
669 |
0.0634 |
| 3 |
BLOOD IMMUNOGLOBULIN M INCREASED |
32 |
0.0526 |
| 4 |
C-REACTIVE PROTEIN |
46 |
0.0496 |
| 5 |
BLOOD IMMUNOGLOBULIN A DECREASED |
32 |
0.0492 |
| 6 |
PRODUCT COATING ISSUE |
49 |
0.0480 |
| 7 |
ANTACID THERAPY |
6 |
0.0462 |
| 8 |
PRODUCT PHYSICAL ISSUE |
916 |
0.0454 |
| 9 |
MILK-ALKALI SYNDROME |
23 |
0.0440 |
| 10 |
PRODUCT COLOUR ISSUE |
225 |
0.0438 |
| 11 |
PEPTOSTREPTOCOCCUS INFECTION |
4 |
0.0381 |
| 12 |
PRODUCT AFTER TASTE |
33 |
0.0346 |
| 13 |
MALIGNANT MELANOMA STAGE 0 |
7 |
0.0335 |
| 14 |
PRODUCT TASTE ABNORMAL |
451 |
0.0333 |
| 15 |
BLOOD TRIGLYCERIDES ABNORMAL |
29 |
0.0331 |
| 16 |
HYPOCHOLESTEROLAEMIA |
11 |
0.0312 |
| 17 |
CONGENITAL HIATUS HERNIA |
7 |
0.0307 |
| 18 |
SLEEP DISORDER THERAPY |
6 |
0.0303 |
| 19 |
BLOOD IMMUNOGLOBULIN G INCREASED |
32 |
0.0263 |
| 20 |
RHEUMATIC DISORDER |
42 |
0.0217 |
| 21 |
INTENTIONAL UNDERDOSE |
158 |
0.0216 |
| 22 |
ANTICOAGULANT THERAPY |
6 |
0.0211 |
| 23 |
FACET JOINT SYNDROME |
64 |
0.0196 |
| 24 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
13 |
0.0195 |
| 25 |
LUPUS VULGARIS |
24 |
0.0190 |
| 26 |
ANALGESIC THERAPY |
6 |
0.0187 |
| 27 |
PRODUCT SIZE ISSUE |
97 |
0.0180 |
| 28 |
PRODUCT LEAKAGE |
100 |
0.0178 |
| 29 |
DRUG THERAPY |
6 |
0.0177 |
| 30 |
BLOOD TRIGLYCERIDES INCREASED |
312 |
0.0176 |
| 31 |
RETINITIS |
30 |
0.0174 |
| 32 |
PORPHYRIA ACUTE |
23 |
0.0160 |
| 33 |
HYDROURETER |
6 |
0.0158 |
| 34 |
PRESCRIBED UNDERDOSE |
314 |
0.0157 |
| 35 |
SERONEGATIVE ARTHRITIS |
17 |
0.0148 |
| 36 |
ERUCTATION |
281 |
0.0145 |
| 37 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
26 |
0.0130 |
| 38 |
BLOOD TRIGLYCERIDES DECREASED |
4 |
0.0119 |
| 39 |
X-RAY ABNORMAL |
20 |
0.0112 |
| 40 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
6 |
0.0107 |
| 41 |
MUSCLE INJURY |
86 |
0.0104 |
| 42 |
HEPATIC NECROSIS |
39 |
0.0103 |
| 43 |
DRUG TOLERANCE DECREASED |
29 |
0.0103 |
| 44 |
HELICOBACTER INFECTION |
98 |
0.0095 |
| 45 |
COLITIS MICROSCOPIC |
44 |
0.0093 |
| 46 |
DUODENAL ULCER PERFORATION |
69 |
0.0093 |
| 47 |
DISLOCATION OF VERTEBRA |
21 |
0.0092 |
| 48 |
C-REACTIVE PROTEIN ABNORMAL |
59 |
0.0092 |
| 49 |
BREAST CANCER STAGE III |
59 |
0.0091 |
| 50 |
SWOLLEN JOINT COUNT INCREASED |
29 |
0.0091 |
| 51 |
PRODUCT RESIDUE PRESENT |
49 |
0.0091 |
| 52 |
RHEUMATIC FEVER |
39 |
0.0087 |
| 53 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
18 |
0.0087 |
| 54 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
55 |
0.0085 |
| 55 |
LIP DRY |
72 |
0.0079 |
| 56 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
7 |
0.0076 |
| 57 |
CATARACT OPERATION |
44 |
0.0074 |
| 58 |
CARDIOVERSION |
10 |
0.0072 |
| 59 |
PERIPHERAL VENOUS DISEASE |
29 |
0.0071 |
| 60 |
LIVE BIRTH |
59 |
0.0070 |
| 61 |
HEPATIC ENZYME ABNORMAL |
35 |
0.0070 |
| 62 |
PEMPHIGUS |
87 |
0.0070 |
| 63 |
PRODUCT CONTAINER SEAL ISSUE |
12 |
0.0069 |
| 64 |
HYPOCHLORAEMIA |
8 |
0.0068 |
| 65 |
GASTROINTESTINAL POLYP HAEMORRHAGE |
4 |
0.0066 |
| 66 |
LOW DENSITY LIPOPROTEIN ABNORMAL |
4 |
0.0065 |
| 67 |
SCIATICA |
104 |
0.0065 |
| 68 |
CALCULUS URINARY |
10 |
0.0065 |
| 69 |
WOUND INFECTION |
70 |
0.0064 |
| 70 |
NAIL DISORDER |
55 |
0.0063 |
| 71 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
45 |
0.0063 |
| 72 |
PANCREATITIS RELAPSING |
5 |
0.0061 |
| 73 |
HAND DEFORMITY |
79 |
0.0060 |
| 74 |
BRONCHITIS VIRAL |
4 |
0.0059 |
| 75 |
SUSPECTED PRODUCT CONTAMINATION |
6 |
0.0059 |
| 76 |
MULTIPLE ALLERGIES |
45 |
0.0057 |
| 77 |
BONE DEMINERALISATION |
6 |
0.0057 |
| 78 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
6 |
0.0056 |
| 79 |
BONE EROSION |
19 |
0.0054 |
| 80 |
RHEUMATOID FACTOR POSITIVE |
31 |
0.0054 |
| 81 |
BREATH ODOUR |
13 |
0.0053 |
| 82 |
JOINT DESTRUCTION |
8 |
0.0051 |
| 83 |
EYELID RASH |
5 |
0.0051 |
| 84 |
HIGH DENSITY LIPOPROTEIN DECREASED |
17 |
0.0051 |
| 85 |
FOREIGN BODY IN THROAT |
16 |
0.0051 |
| 86 |
CARDIAC ABLATION |
9 |
0.0050 |
| 87 |
BURSITIS |
61 |
0.0050 |
| 88 |
PERICARDITIS |
84 |
0.0050 |
| 89 |
LOW DENSITY LIPOPROTEIN DECREASED |
7 |
0.0049 |
| 90 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
54 |
0.0049 |
| 91 |
HEPATIC ENCEPHALOPATHY |
45 |
0.0048 |
| 92 |
HYPERPARATHYROIDISM SECONDARY |
12 |
0.0048 |
| 93 |
PERIORBITAL PAIN |
4 |
0.0047 |
| 94 |
SYNOVITIS |
85 |
0.0047 |
| 95 |
HYPERPHOSPHATAEMIA |
10 |
0.0046 |
| 96 |
FIBROMYALGIA |
112 |
0.0046 |
| 97 |
FOREIGN BODY IN RESPIRATORY TRACT |
6 |
0.0046 |
| 98 |
HISTOPLASMOSIS |
8 |
0.0045 |
| 99 |
HYPERTRIGLYCERIDAEMIA |
26 |
0.0044 |
| 100 |
ULCER HAEMORRHAGE |
30 |
0.0044 |
| 101 |
TYPE 2 DIABETES MELLITUS |
145 |
0.0043 |
| 102 |
OBESITY |
68 |
0.0043 |
| 103 |
GOUT |
75 |
0.0042 |
| 104 |
RETCHING |
89 |
0.0042 |
| 105 |
PROSTATIC OPERATION |
5 |
0.0041 |
| 106 |
SPONDYLITIS |
15 |
0.0041 |
| 107 |
PRODUCT ADHESION ISSUE |
146 |
0.0041 |
| 108 |
INFUSION SITE REACTION |
12 |
0.0040 |
| 109 |
FOLLICULITIS |
42 |
0.0040 |
| 110 |
PANCREATITIS NECROTISING |
9 |
0.0039 |
| 111 |
NEPHROGENIC ANAEMIA |
18 |
0.0039 |
| 112 |
SKIN ODOUR ABNORMAL |
15 |
0.0038 |
| 113 |
PSORIATIC ARTHROPATHY |
154 |
0.0038 |
| 114 |
REGURGITATION |
13 |
0.0038 |
| 115 |
EYE INJURY |
11 |
0.0036 |
| 116 |
DRUG-INDUCED LIVER INJURY |
112 |
0.0036 |
| 117 |
HEPATIC CIRRHOSIS |
66 |
0.0035 |
| 118 |
PRODUCT DISPENSING ISSUE |
15 |
0.0035 |
| 119 |
LOW DENSITY LIPOPROTEIN INCREASED |
27 |
0.0035 |
| 120 |
PRESCRIBED OVERDOSE |
67 |
0.0035 |
| 121 |
HYPERCHOLESTEROLAEMIA |
33 |
0.0034 |
| 122 |
BLEPHAROSPASM |
21 |
0.0033 |
| 123 |
PRODUCT CONTAINER ISSUE |
28 |
0.0033 |
| 124 |
PLEURITIC PAIN |
9 |
0.0033 |
| 125 |
LIVER INJURY |
80 |
0.0033 |
| 126 |
PRODUCT USE COMPLAINT |
51 |
0.0032 |
| 127 |
THERAPY INTERRUPTED |
226 |
0.0032 |
| 128 |
SKIN REACTION |
44 |
0.0031 |
| 129 |
LOWER LIMB FRACTURE |
60 |
0.0031 |
| 130 |
IMMUNE-MEDIATED MYOCARDITIS |
5 |
0.0031 |
| 131 |
JOINT RANGE OF MOTION DECREASED |
41 |
0.0031 |
| 132 |
CONTRAINDICATED PRODUCT ADMINISTERED |
92 |
0.0030 |
| 133 |
HYPOPHOSPHATAEMIA |
22 |
0.0030 |
| 134 |
AUTOIMMUNE DISORDER |
29 |
0.0030 |
| 135 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
11 |
0.0029 |
| 136 |
PANNICULITIS |
7 |
0.0029 |
| 137 |
IMMUNODEFICIENCY |
43 |
0.0029 |
| 138 |
ONYCHOMADESIS |
12 |
0.0029 |
| 139 |
RESPIRATORY SYMPTOM |
8 |
0.0028 |
| 140 |
C-REACTIVE PROTEIN INCREASED |
100 |
0.0027 |
| 141 |
ESSENTIAL HYPERTENSION |
5 |
0.0027 |
| 142 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
9 |
0.0027 |
| 143 |
OSTEOARTHRITIS |
114 |
0.0027 |
| 144 |
HERNIA |
51 |
0.0026 |
| 145 |
CARDIAC FLUTTER |
17 |
0.0026 |
| 146 |
MUSCULOSKELETAL PAIN |
135 |
0.0026 |
| 147 |
NEOPLASM SKIN |
4 |
0.0026 |
| 148 |
PULMONARY FIBROSIS |
49 |
0.0026 |
| 149 |
URINE ODOUR ABNORMAL |
15 |
0.0025 |
| 150 |
MEDICATION RESIDUE PRESENT |
12 |
0.0025 |
| 151 |
BLOOD CHOLESTEROL INCREASED |
117 |
0.0025 |
| 152 |
MULTIPLE FRACTURES |
41 |
0.0025 |
| 153 |
IMPAIRED GASTRIC EMPTYING |
34 |
0.0025 |
| 154 |
MOBILITY DECREASED |
179 |
0.0025 |
| 155 |
SPINAL FUSION SURGERY |
10 |
0.0025 |
| 156 |
JOINT DISLOCATION |
26 |
0.0025 |
| 157 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
42 |
0.0024 |
| 158 |
CARTILAGE INJURY |
6 |
0.0024 |
| 159 |
HAEMOGLOBIN INCREASED |
11 |
0.0024 |
| 160 |
PRODUCT LABEL ISSUE |
16 |
0.0024 |
| 161 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
83 |
0.0023 |
| 162 |
GLAUCOMA |
45 |
0.0023 |
| 163 |
BENIGN PROSTATIC HYPERPLASIA |
12 |
0.0023 |
| 164 |
DIVERTICULITIS |
64 |
0.0023 |
| 165 |
EXOSTOSIS |
21 |
0.0023 |
| 166 |
COLONOSCOPY |
5 |
0.0023 |
| 167 |
MULTIPLE-DRUG RESISTANCE |
7 |
0.0023 |
| 168 |
STENT PLACEMENT |
18 |
0.0022 |
| 169 |
LUPUS-LIKE SYNDROME |
20 |
0.0022 |
| 170 |
ARTHROPATHY |
122 |
0.0022 |
| 171 |
ROAD TRAFFIC ACCIDENT |
91 |
0.0022 |
| 172 |
CORONARY ARTERIAL STENT INSERTION |
11 |
0.0022 |
| 173 |
IRRITABLE BOWEL SYNDROME |
46 |
0.0021 |
| 174 |
STOMATITIS |
130 |
0.0021 |
| 175 |
HEPATOTOXICITY |
47 |
0.0021 |
| 176 |
WEIGHT FLUCTUATION |
22 |
0.0021 |
| 177 |
CORONARY ARTERY BYPASS |
12 |
0.0021 |
| 178 |
BLOOD URIC ACID INCREASED |
12 |
0.0021 |
| 179 |
IMMUNE-MEDIATED HEPATIC DISORDER |
4 |
0.0020 |
| 180 |
PRODUCT ADMINISTRATION INTERRUPTED |
16 |
0.0020 |
| 181 |
JOINT NOISE |
4 |
0.0020 |
| 182 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
91 |
0.0020 |
| 183 |
GLUCOSE TOLERANCE IMPAIRED |
12 |
0.0020 |
| 184 |
END STAGE RENAL DISEASE |
37 |
0.0020 |
| 185 |
HYPERTRANSAMINASAEMIA |
14 |
0.0020 |
| 186 |
AORTIC STENOSIS |
7 |
0.0020 |
| 187 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
44 |
0.0020 |
| 188 |
WALKING AID USER |
13 |
0.0020 |
| 189 |
PRODUCT CONTAMINATION |
7 |
0.0020 |
| 190 |
LOWER RESPIRATORY TRACT INFECTION |
89 |
0.0020 |
| 191 |
CHANGE OF BOWEL HABIT |
4 |
0.0019 |
| 192 |
BLOOD CHOLESTEROL ABNORMAL |
9 |
0.0019 |
| 193 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
12 |
0.0019 |
| 194 |
PHYSICAL DECONDITIONING |
5 |
0.0019 |
| 195 |
UNDERDOSE |
141 |
0.0019 |
| 196 |
EPILEPSY |
58 |
0.0019 |
| 197 |
NON-CARDIAC CHEST PAIN |
6 |
0.0019 |
| 198 |
HIP ARTHROPLASTY |
29 |
0.0019 |
| 199 |
PRODUCT DISPENSING ERROR |
41 |
0.0019 |
| 200 |
CARDIAC FAILURE CHRONIC |
8 |
0.0019 |
| 201 |
GLOSSODYNIA |
41 |
0.0018 |
| 202 |
TASTE DISORDER |
37 |
0.0018 |
| 203 |
THERAPEUTIC RESPONSE UNEXPECTED |
81 |
0.0018 |
| 204 |
GASTRIC ULCER HAEMORRHAGE |
10 |
0.0018 |
| 205 |
FOOT DEFORMITY |
20 |
0.0018 |
| 206 |
MATERNAL EXPOSURE DURING PREGNANCY |
160 |
0.0018 |
| 207 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
9 |
0.0018 |
| 208 |
GASTROINTESTINAL HYPOMOTILITY |
4 |
0.0018 |
| 209 |
DYSLIPIDAEMIA |
9 |
0.0018 |
| 210 |
DISTRIBUTIVE SHOCK |
4 |
0.0018 |
| 211 |
MYASTHENIA GRAVIS |
14 |
0.0017 |
| 212 |
GLOMERULAR FILTRATION RATE DECREASED |
21 |
0.0017 |
| 213 |
TROPONIN INCREASED |
13 |
0.0017 |
| 214 |
GRIP STRENGTH DECREASED |
15 |
0.0017 |
| 215 |
DYSGEUSIA |
126 |
0.0017 |
| 216 |
RADIUS FRACTURE |
4 |
0.0017 |
| 217 |
PAINFUL RESPIRATION |
4 |
0.0017 |
| 218 |
ABDOMINAL DISCOMFORT |
278 |
0.0017 |
| 219 |
LIVER FUNCTION TEST INCREASED |
35 |
0.0016 |
| 220 |
CARDIAC OPERATION |
14 |
0.0016 |
| 221 |
PORTAL HYPERTENSION |
5 |
0.0016 |
| 222 |
IMPAIRED HEALING |
53 |
0.0016 |
| 223 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
40 |
0.0016 |
| 224 |
SINUSITIS |
164 |
0.0016 |
| 225 |
HEPATIC ENZYME INCREASED |
109 |
0.0016 |
| 226 |
CATHETERISATION CARDIAC |
7 |
0.0016 |
| 227 |
PRODUCT CONTAMINATION PHYSICAL |
4 |
0.0016 |
| 228 |
WOUND |
44 |
0.0016 |
| 229 |
PARANASAL SINUS HYPERSECRETION |
6 |
0.0016 |
| 230 |
HAEMORRHAGE URINARY TRACT |
4 |
0.0016 |
| 231 |
DYSPEPSIA |
154 |
0.0016 |
| 232 |
BACK INJURY |
17 |
0.0016 |
| 233 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
75 |
0.0016 |
| 234 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
8 |
0.0016 |
| 235 |
FOOD ALLERGY |
12 |
0.0016 |
| 236 |
BLOOD CHLORIDE DECREASED |
4 |
0.0015 |
| 237 |
CYSTITIS |
49 |
0.0015 |
| 238 |
EYE DISORDER |
50 |
0.0015 |
| 239 |
DRUG RESISTANCE |
39 |
0.0015 |
| 240 |
POLYDIPSIA |
6 |
0.0015 |
| 241 |
LUNG OPACITY |
4 |
0.0015 |
| 242 |
POLYARTHRITIS |
8 |
0.0015 |
| 243 |
SWELLING |
142 |
0.0015 |
| 244 |
FAECES SOFT |
11 |
0.0015 |
| 245 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
4 |
0.0015 |
| 246 |
OEDEMA |
81 |
0.0015 |
| 247 |
KNEE ARTHROPLASTY |
31 |
0.0015 |
| 248 |
CORONARY ARTERY OCCLUSION |
20 |
0.0015 |
| 249 |
PUSTULAR PSORIASIS |
5 |
0.0015 |
| 250 |
SPINAL STENOSIS |
6 |
0.0015 |
| 251 |
IMMUNE-MEDIATED MYOSITIS |
4 |
0.0014 |
| 252 |
CHOKING SENSATION |
8 |
0.0014 |
| 253 |
WHEEZING |
86 |
0.0014 |
| 254 |
GRANULOMA |
5 |
0.0014 |
| 255 |
THROAT CANCER |
6 |
0.0014 |
| 256 |
ATRIAL FIBRILLATION |
137 |
0.0014 |
| 257 |
FREQUENT BOWEL MOVEMENTS |
38 |
0.0014 |
| 258 |
GAIT INABILITY |
47 |
0.0014 |
| 259 |
SHOULDER OPERATION |
6 |
0.0014 |
| 260 |
EAR INFECTION |
37 |
0.0014 |
| 261 |
INFLAMMATION |
71 |
0.0014 |
| 262 |
ABNORMAL FAECES |
11 |
0.0013 |
| 263 |
HEPATIC STEATOSIS |
25 |
0.0013 |
| 264 |
GASTROOESOPHAGEAL REFLUX DISEASE |
108 |
0.0013 |
| 265 |
HYPERLIPIDAEMIA |
16 |
0.0013 |
| 266 |
CHOKING |
26 |
0.0013 |
| 267 |
CHRONIC KIDNEY DISEASE |
101 |
0.0013 |
| 268 |
BRONCHITIS |
98 |
0.0013 |
| 269 |
IRITIS |
4 |
0.0013 |
| 270 |
PERIPHERAL SWELLING |
202 |
0.0013 |
| 271 |
INSURANCE ISSUE |
20 |
0.0013 |
| 272 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
33 |
0.0013 |
| 273 |
DRUG INTOLERANCE |
126 |
0.0013 |
| 274 |
OESOPHAGEAL DISORDER |
5 |
0.0013 |
| 275 |
INTENTIONAL DOSE OMISSION |
37 |
0.0013 |
| 276 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
4 |
0.0013 |
| 277 |
THERAPY NON-RESPONDER |
58 |
0.0013 |
| 278 |
IMMUNE SYSTEM DISORDER |
17 |
0.0013 |
| 279 |
PANCREATITIS |
68 |
0.0013 |
| 280 |
ASPIRATION |
14 |
0.0013 |
| 281 |
BLOOD MAGNESIUM DECREASED |
11 |
0.0013 |
| 282 |
NIGHT SWEATS |
41 |
0.0013 |
| 283 |
FLATULENCE |
72 |
0.0013 |
| 284 |
INFUSION SITE PRURITUS |
4 |
0.0013 |
| 285 |
OSTEOPOROSIS |
52 |
0.0013 |
| 286 |
HYPOAESTHESIA |
189 |
0.0013 |
| 287 |
RHEUMATOID ARTHRITIS |
142 |
0.0012 |
| 288 |
MYELOSUPPRESSION |
45 |
0.0012 |
| 289 |
CUSHINGOID |
4 |
0.0012 |
| 290 |
DIZZINESS POSTURAL |
12 |
0.0012 |
| 291 |
ANGINA UNSTABLE |
8 |
0.0012 |
| 292 |
POLYP |
8 |
0.0012 |
| 293 |
HYPOMAGNESAEMIA |
17 |
0.0012 |
| 294 |
BREATH SOUNDS ABNORMAL |
6 |
0.0012 |
| 295 |
FOOT OPERATION |
6 |
0.0012 |
| 296 |
JOINT SWELLING |
146 |
0.0012 |
| 297 |
ARTHRALGIA |
501 |
0.0012 |
| 298 |
HYDRONEPHROSIS |
9 |
0.0012 |
| 299 |
PRODUCT LABEL CONFUSION |
7 |
0.0012 |
| 300 |
CORONARY ARTERY STENOSIS |
6 |
0.0012 |
| 301 |
PAROSMIA |
9 |
0.0012 |
| 302 |
CATARACT |
71 |
0.0012 |
| 303 |
PRODUCT SOLUBILITY ABNORMAL |
6 |
0.0012 |
| 304 |
INFUSION RELATED REACTION |
78 |
0.0012 |
| 305 |
ALANINE AMINOTRANSFERASE INCREASED |
72 |
0.0012 |
| 306 |
BACK DISORDER |
19 |
0.0012 |
| 307 |
HEPATIC FIBROSIS |
4 |
0.0012 |
| 308 |
PRODUCT PACKAGING ISSUE |
11 |
0.0012 |
| 309 |
FOETAL DEATH |
6 |
0.0012 |
| 310 |
ADRENAL INSUFFICIENCY |
14 |
0.0012 |
| 311 |
POLYMENORRHOEA |
4 |
0.0012 |
| 312 |
ELECTROCARDIOGRAM ABNORMAL |
9 |
0.0011 |
| 313 |
DIVERTICULUM INTESTINAL |
5 |
0.0011 |
| 314 |
ANHEDONIA |
30 |
0.0011 |
| 315 |
BLOOD GLUCOSE INCREASED |
215 |
0.0011 |
| 316 |
FULL BLOOD COUNT ABNORMAL |
12 |
0.0011 |
| 317 |
PRODUCT STORAGE ERROR |
99 |
0.0011 |
| 318 |
NASOPHARYNGITIS |
207 |
0.0011 |
| 319 |
TREATMENT FAILURE |
93 |
0.0011 |
| 320 |
INFUSION SITE SWELLING |
7 |
0.0011 |
| 321 |
ANAL INCONTINENCE |
10 |
0.0011 |
| 322 |
NORMAL NEWBORN |
6 |
0.0011 |
| 323 |
INCREASED APPETITE |
21 |
0.0011 |
| 324 |
BLOOD GLUCOSE FLUCTUATION |
12 |
0.0011 |
| 325 |
EYE OPERATION |
5 |
0.0011 |
| 326 |
LIVER DISORDER |
48 |
0.0011 |
| 327 |
BREAST CANCER STAGE II |
9 |
0.0011 |
| 328 |
RENAL FUNCTION TEST ABNORMAL |
5 |
0.0011 |
| 329 |
BONE DENSITY ABNORMAL |
4 |
0.0011 |
| 330 |
URTICARIA |
179 |
0.0011 |
| 331 |
NEPHROLITHIASIS |
49 |
0.0011 |
| 332 |
ANAPHYLACTIC REACTION |
59 |
0.0011 |
| 333 |
SEASONAL ALLERGY |
15 |
0.0011 |
| 334 |
BLOOD PRESSURE INCREASED |
162 |
0.0011 |
| 335 |
MYALGIA |
180 |
0.0011 |
| 336 |
CORONAVIRUS INFECTION |
7 |
0.0011 |
| 337 |
CORONARY ARTERY DISEASE |
32 |
0.0011 |
| 338 |
APPETITE DISORDER |
7 |
0.0011 |
| 339 |
FACE INJURY |
4 |
0.0011 |
| 340 |
CONTUSION |
101 |
0.0010 |
| 341 |
RECALLED PRODUCT ADMINISTERED |
10 |
0.0010 |
| 342 |
BLOOD POTASSIUM INCREASED |
17 |
0.0010 |
| 343 |
LUNG DISORDER |
51 |
0.0010 |
| 344 |
RASH VESICULAR |
5 |
0.0010 |
| 345 |
COELIAC DISEASE |
10 |
0.0010 |
| 346 |
ARTERIAL OCCLUSIVE DISEASE |
8 |
0.0010 |
| 347 |
ARTHRITIS |
80 |
0.0010 |
| 348 |
DISCOMFORT |
62 |
0.0010 |
| 349 |
WEIGHT INCREASED |
227 |
0.0010 |
| 350 |
HYPERVOLAEMIA |
5 |
0.0010 |
| 351 |
TRICUSPID VALVE INCOMPETENCE |
8 |
0.0010 |
| 352 |
INTENTIONAL PRODUCT USE ISSUE |
88 |
0.0010 |
| 353 |
HYPERPHAGIA |
4 |
0.0010 |
| 354 |
ATRIAL FLUTTER |
8 |
0.0010 |
| 355 |
BLOOD TEST ABNORMAL |
14 |
0.0010 |
| 356 |
ABDOMINAL PAIN UPPER |
205 |
0.0010 |
| 357 |
GALLBLADDER OPERATION |
4 |
0.0010 |
| 358 |
MUSCLE TIGHTNESS |
16 |
0.0010 |
| 359 |
SARS-COV-2 TEST POSITIVE |
13 |
0.0010 |
| 360 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
4 |
0.0010 |
| 361 |
SLEEP DISORDER |
69 |
0.0010 |
| 362 |
IRON DEFICIENCY ANAEMIA |
9 |
0.0010 |
| 363 |
HYPERURICAEMIA |
4 |
0.0010 |
| 364 |
PRODUCT DISTRIBUTION ISSUE |
9 |
0.0010 |
| 365 |
PRE-EXISTING CONDITION IMPROVED |
6 |
0.0010 |
| 366 |
MYOCARDITIS |
11 |
0.0010 |
| 367 |
DIABETES MELLITUS |
73 |
0.0010 |
| 368 |
DIARRHOEA |
614 |
0.0010 |
| 369 |
ARTHROPOD BITE |
7 |
0.0009 |
| 370 |
CONDITION AGGRAVATED |
286 |
0.0009 |
| 371 |
HERPES ZOSTER |
54 |
0.0009 |
| 372 |
FEEDING DISORDER |
19 |
0.0009 |
| 373 |
FOOD POISONING |
5 |
0.0009 |
| 374 |
ATELECTASIS |
9 |
0.0009 |
| 375 |
NEUROLEPTIC MALIGNANT SYNDROME |
11 |
0.0009 |
| 376 |
HIP SURGERY |
5 |
0.0009 |
| 377 |
OSTEOPENIA |
14 |
0.0009 |
| 378 |
PRODUCT AVAILABILITY ISSUE |
21 |
0.0009 |
| 379 |
TENDON DISORDER |
6 |
0.0009 |
| 380 |
BLOOD CALCIUM INCREASED |
8 |
0.0009 |
| 381 |
TOOTH INFECTION |
12 |
0.0009 |
| 382 |
OFF LABEL USE |
796 |
0.0009 |
| 383 |
GASTROINTESTINAL PAIN |
10 |
0.0009 |
| 384 |
PAIN IN EXTREMITY |
267 |
0.0009 |
| 385 |
GINGIVAL SWELLING |
4 |
0.0009 |
| 386 |
BLOOD PRESSURE ABNORMAL |
18 |
0.0009 |
| 387 |
RENAL IMPAIRMENT |
76 |
0.0009 |
| 388 |
BLOOD CREATINE INCREASED |
4 |
0.0009 |
| 389 |
PREGNANCY |
18 |
0.0009 |
| 390 |
THIRST |
16 |
0.0009 |
| 391 |
MUSCULOSKELETAL STIFFNESS |
78 |
0.0009 |
| 392 |
DRY MOUTH |
72 |
0.0009 |
| 393 |
OROPHARYNGEAL DISCOMFORT |
8 |
0.0009 |
| 394 |
ACUTE RESPIRATORY FAILURE |
17 |
0.0009 |
| 395 |
PRODUCT DOSE OMISSION IN ERROR |
25 |
0.0009 |
| 396 |
BLOOD PRESSURE SYSTOLIC DECREASED |
4 |
0.0009 |
| 397 |
HYPERTENSION |
186 |
0.0009 |
| 398 |
BLOOD TESTOSTERONE DECREASED |
6 |
0.0009 |
| 399 |
MICTURITION URGENCY |
10 |
0.0009 |
| 400 |
IMMUNE THROMBOCYTOPENIA |
4 |
0.0009 |
| 401 |
MUSCLE SPASMS |
159 |
0.0009 |
| 402 |
LARGE INTESTINE POLYP |
6 |
0.0009 |
| 403 |
EXTRASYSTOLES |
6 |
0.0009 |
| 404 |
MASS |
12 |
0.0009 |
| 405 |
SINUS DISORDER |
17 |
0.0009 |
| 406 |
THERAPY CESSATION |
44 |
0.0009 |
| 407 |
BLISTER |
48 |
0.0009 |
| 408 |
FLANK PAIN |
8 |
0.0009 |
| 409 |
UPPER-AIRWAY COUGH SYNDROME |
7 |
0.0008 |
| 410 |
RASH PRURITIC |
46 |
0.0008 |
| 411 |
GASTRIC ULCER |
16 |
0.0008 |
| 412 |
CARDIAC PACEMAKER INSERTION |
5 |
0.0008 |
| 413 |
NON-SMALL CELL LUNG CANCER |
4 |
0.0008 |
| 414 |
ACCIDENTAL UNDERDOSE |
12 |
0.0008 |
| 415 |
BRAIN FOG |
13 |
0.0008 |
| 416 |
PULMONARY ARTERIAL HYPERTENSION |
12 |
0.0008 |
| 417 |
NOCTURIA |
10 |
0.0008 |
| 418 |
NECK PAIN |
46 |
0.0008 |
| 419 |
UPPER RESPIRATORY TRACT INFECTION |
38 |
0.0008 |
| 420 |
CONSTIPATION |
179 |
0.0008 |
| 421 |
HAEMORRHOIDAL HAEMORRHAGE |
4 |
0.0008 |
| 422 |
VITAMIN D DECREASED |
7 |
0.0008 |
| 423 |
ULCER |
13 |
0.0008 |
| 424 |
PRODUCT DOSE OMISSION ISSUE |
240 |
0.0008 |
| 425 |
SINUS CONGESTION |
11 |
0.0008 |
| 426 |
ADVERSE EVENT |
75 |
0.0008 |
| 427 |
SPINAL OPERATION |
10 |
0.0008 |
| 428 |
CONCOMITANT DISEASE AGGRAVATED |
5 |
0.0008 |
| 429 |
PROTEIN URINE PRESENT |
4 |
0.0008 |
| 430 |
DYSPHAGIA |
76 |
0.0008 |
| 431 |
JOINT STIFFNESS |
21 |
0.0008 |
| 432 |
GENERAL SYMPTOM |
6 |
0.0008 |
| 433 |
MITRAL VALVE INCOMPETENCE |
9 |
0.0008 |
| 434 |
GASTROINTESTINAL DISORDER |
71 |
0.0008 |
| 435 |
BLOOD GLUCOSE DECREASED |
38 |
0.0008 |
| 436 |
FOOT FRACTURE |
15 |
0.0008 |
| 437 |
ALOPECIA |
155 |
0.0008 |
| 438 |
CHOLECYSTECTOMY |
9 |
0.0008 |
| 439 |
MIGRAINE |
75 |
0.0008 |
| 440 |
HYPOTHYROIDISM |
25 |
0.0008 |
| 441 |
PLATELET COUNT DECREASED |
83 |
0.0008 |
| 442 |
PERIPHERAL VASCULAR DISORDER |
4 |
0.0008 |
| 443 |
INFUSION SITE PAIN |
10 |
0.0008 |
| 444 |
CONGENITAL ANOMALY |
6 |
0.0008 |
| 445 |
EAR PAIN |
15 |
0.0008 |
| 446 |
ADVERSE DRUG REACTION |
69 |
0.0008 |
| 447 |
INJURY |
54 |
0.0008 |
| 448 |
MALABSORPTION |
4 |
0.0008 |
| 449 |
COVID-19 PNEUMONIA |
9 |
0.0008 |
| 450 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
7 |
0.0008 |
| 451 |
INCONTINENCE |
8 |
0.0008 |
| 452 |
ABDOMINAL DISTENSION |
78 |
0.0007 |
| 453 |
INSOMNIA |
197 |
0.0007 |
| 454 |
WHITE BLOOD CELL COUNT DECREASED |
80 |
0.0007 |
| 455 |
HYPOKALAEMIA |
34 |
0.0007 |
| 456 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
10 |
0.0007 |
| 457 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
147 |
0.0007 |
| 458 |
COVID-19 |
127 |
0.0007 |
| 459 |
DECREASED APPETITE |
168 |
0.0007 |
| 460 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
4 |
0.0007 |
| 461 |
HEART RATE ABNORMAL |
4 |
0.0007 |
| 462 |
PULMONARY ALVEOLAR HAEMORRHAGE |
4 |
0.0007 |
| 463 |
OROPHARYNGEAL PAIN |
66 |
0.0007 |
| 464 |
HEPATOMEGALY |
7 |
0.0007 |
| 465 |
PANCREATITIS ACUTE |
16 |
0.0007 |
| 466 |
GENERAL PHYSICAL HEALTH DETERIORATION |
82 |
0.0007 |
| 467 |
BLOOD PRESSURE DECREASED |
47 |
0.0007 |
| 468 |
PULMONARY TOXICITY |
5 |
0.0007 |
| 469 |
CHOLECYSTITIS ACUTE |
4 |
0.0007 |
| 470 |
ROTATOR CUFF SYNDROME |
9 |
0.0007 |
| 471 |
PRODUCT SUPPLY ISSUE |
5 |
0.0007 |
| 472 |
INTERNAL HAEMORRHAGE |
8 |
0.0007 |
| 473 |
BLOOD POTASSIUM DECREASED |
21 |
0.0007 |
| 474 |
NAUSEA |
552 |
0.0007 |
| 475 |
MUSCULOSKELETAL DISCOMFORT |
12 |
0.0007 |
| 476 |
HEPATIC FUNCTION ABNORMAL |
26 |
0.0007 |
| 477 |
POLLAKIURIA |
29 |
0.0007 |
| 478 |
EXERCISE TOLERANCE DECREASED |
4 |
0.0007 |
| 479 |
MUSCLE STRAIN |
6 |
0.0007 |
| 480 |
PRODUCT ADMINISTRATION ERROR |
14 |
0.0007 |
| 481 |
PYELONEPHRITIS |
6 |
0.0007 |
| 482 |
DELIRIUM |
24 |
0.0007 |
| 483 |
EYE PAIN |
39 |
0.0007 |
| 484 |
URINE OUTPUT DECREASED |
6 |
0.0007 |
| 485 |
SPINAL PAIN |
8 |
0.0007 |
| 486 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
123 |
0.0007 |
| 487 |
PRODUCT COMMUNICATION ISSUE |
6 |
0.0007 |
| 488 |
ACUTE KIDNEY INJURY |
104 |
0.0007 |
| 489 |
SENSITIVE SKIN |
5 |
0.0007 |
| 490 |
ASPARTATE AMINOTRANSFERASE INCREASED |
36 |
0.0007 |
| 491 |
HOT FLUSH |
51 |
0.0007 |
| 492 |
VENTRICULAR EXTRASYSTOLES |
7 |
0.0007 |
| 493 |
CHOLECYSTITIS |
8 |
0.0007 |
| 494 |
PULMONARY MASS |
10 |
0.0007 |
| 495 |
PAIN IN JAW |
19 |
0.0007 |
| 496 |
ODYNOPHAGIA |
4 |
0.0007 |
| 497 |
MYOSITIS |
6 |
0.0007 |
| 498 |
INJECTION SITE DISCOMFORT |
7 |
0.0007 |
| 499 |
BREAST TENDERNESS |
5 |
0.0007 |
| 500 |
HEART RATE IRREGULAR |
15 |
0.0007 |
| 501 |
DRUG INTERACTION |
105 |
0.0007 |
| 502 |
TENDON PAIN |
5 |
0.0007 |
| 503 |
RENAL PAIN |
7 |
0.0007 |
| 504 |
PRODUCT USE ISSUE |
124 |
0.0007 |
| 505 |
TREATMENT NONCOMPLIANCE |
36 |
0.0007 |
| 506 |
PALPITATIONS |
77 |
0.0007 |
| 507 |
DISABILITY |
13 |
0.0007 |
| 508 |
CONFUSIONAL STATE |
106 |
0.0007 |
| 509 |
JOINT INJURY |
14 |
0.0007 |
| 510 |
MEMORY IMPAIRMENT |
90 |
0.0007 |
| 511 |
CEREBRAL INFARCTION |
16 |
0.0007 |
| 512 |
PNEUMONIA BACTERIAL |
6 |
0.0007 |
| 513 |
MYOCARDIAL INFARCTION |
114 |
0.0007 |
| 514 |
MENISCUS INJURY |
4 |
0.0006 |
| 515 |
CARDIOMEGALY |
8 |
0.0006 |
| 516 |
DECREASED ACTIVITY |
7 |
0.0006 |
| 517 |
PIGMENTATION DISORDER |
4 |
0.0006 |
| 518 |
HEART RATE INCREASED |
64 |
0.0006 |
| 519 |
FAECES DISCOLOURED |
14 |
0.0006 |
| 520 |
PRODUCT DOSE OMISSION |
42 |
0.0006 |
| 521 |
BACTERIAL INFECTION |
12 |
0.0006 |
| 522 |
PELVIC FRACTURE |
5 |
0.0006 |
| 523 |
ARTERIOSCLEROSIS |
6 |
0.0006 |
| 524 |
RENAL CYST |
5 |
0.0006 |
| 525 |
SLEEP APNOEA SYNDROME |
12 |
0.0006 |
| 526 |
RECTAL HAEMORRHAGE |
27 |
0.0006 |
| 527 |
ASTHMA |
71 |
0.0006 |
| 528 |
BLOOD CREATININE INCREASED |
41 |
0.0006 |
| 529 |
OEDEMA PERIPHERAL |
76 |
0.0006 |
| 530 |
CHEST PAIN |
115 |
0.0006 |
| 531 |
BACK PAIN |
144 |
0.0006 |
| 532 |
NEURALGIA |
15 |
0.0006 |
| 533 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 534 |
DIZZINESS |
305 |
0.0006 |
| 535 |
ACUTE MYOCARDIAL INFARCTION |
18 |
0.0006 |
| 536 |
DRUG EFFECT LESS THAN EXPECTED |
9 |
0.0006 |
| 537 |
HAIR DISORDER |
5 |
0.0006 |
| 538 |
BLADDER DISORDER |
6 |
0.0006 |
| 539 |
COLON CANCER |
9 |
0.0006 |
| 540 |
POOR QUALITY SLEEP |
13 |
0.0006 |
| 541 |
ARTERIOSCLEROSIS CORONARY ARTERY |
4 |
0.0006 |
| 542 |
RESPIRATORY DISORDER |
18 |
0.0006 |
| 543 |
EOSINOPHIL COUNT INCREASED |
5 |
0.0006 |
| 544 |
INTERSTITIAL LUNG DISEASE |
29 |
0.0006 |
| 545 |
HYPERKALAEMIA |
21 |
0.0006 |
| 546 |
MUSCULAR WEAKNESS |
68 |
0.0006 |
| 547 |
SPLENOMEGALY |
7 |
0.0006 |
| 548 |
MALIGNANT MELANOMA |
8 |
0.0006 |
| 549 |
BLOOD GLUCOSE ABNORMAL |
11 |
0.0006 |
| 550 |
ECONOMIC PROBLEM |
9 |
0.0006 |
| 551 |
THERAPEUTIC RESPONSE DECREASED |
36 |
0.0006 |
| 552 |
FATIGUE |
462 |
0.0006 |
| 553 |
INFUSION SITE ERYTHEMA |
5 |
0.0006 |
| 554 |
ILLNESS |
61 |
0.0006 |
| 555 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
17 |
0.0006 |
| 556 |
BLOOD IRON DECREASED |
7 |
0.0006 |
| 557 |
BACTERAEMIA |
7 |
0.0006 |
| 558 |
PRODUCT PRESCRIBING ERROR |
14 |
0.0006 |
| 559 |
PHOTOPHOBIA |
11 |
0.0006 |
| 560 |
INITIAL INSOMNIA |
6 |
0.0006 |
| 561 |
DEVICE RELATED INFECTION |
9 |
0.0006 |
| 562 |
THYROID DISORDER |
9 |
0.0006 |
| 563 |
DIABETIC KETOACIDOSIS |
14 |
0.0006 |
| 564 |
VOMITING |
273 |
0.0006 |
| 565 |
WEIGHT DECREASED |
162 |
0.0006 |
| 566 |
LABORATORY TEST ABNORMAL |
17 |
0.0006 |
| 567 |
CHROMATURIA |
13 |
0.0006 |
| 568 |
INFECTION |
83 |
0.0006 |
| 569 |
RHINORRHOEA |
37 |
0.0006 |
| 570 |
RENAL INJURY |
17 |
0.0006 |
| 571 |
ASTHENIA |
215 |
0.0006 |
| 572 |
DUODENAL ULCER |
4 |
0.0006 |
| 573 |
TENDON RUPTURE |
7 |
0.0006 |
| 574 |
RASH |
246 |
0.0006 |
| 575 |
ILEUS |
7 |
0.0006 |
| 576 |
EXPOSURE DURING PREGNANCY |
35 |
0.0006 |
| 577 |
BREAST PAIN |
6 |
0.0006 |
| 578 |
PERICARDIAL EFFUSION |
13 |
0.0006 |
| 579 |
EPISTAXIS |
42 |
0.0006 |
| 580 |
PNEUMONIA ASPIRATION |
14 |
0.0006 |
| 581 |
INJECTION SITE DISCOLOURATION |
7 |
0.0006 |
| 582 |
PARAESTHESIA ORAL |
8 |
0.0006 |
| 583 |
PHARYNGITIS STREPTOCOCCAL |
6 |
0.0006 |
| 584 |
PRURITUS |
213 |
0.0006 |
| 585 |
LIMB INJURY |
15 |
0.0006 |
| 586 |
RESTLESS LEGS SYNDROME |
10 |
0.0005 |
| 587 |
RENAL FAILURE |
73 |
0.0005 |
| 588 |
LIQUID PRODUCT PHYSICAL ISSUE |
4 |
0.0005 |
| 589 |
DYSSTASIA |
16 |
0.0005 |
| 590 |
DYSPHONIA |
32 |
0.0005 |
| 591 |
HOSPITALISATION |
84 |
0.0005 |
| 592 |
CEREBROVASCULAR ACCIDENT |
92 |
0.0005 |
| 593 |
NERVE COMPRESSION |
5 |
0.0005 |
| 594 |
EXPIRED PRODUCT ADMINISTERED |
18 |
0.0005 |
| 595 |
CONJUNCTIVITIS |
10 |
0.0005 |
| 596 |
LOCALISED INFECTION |
13 |
0.0005 |
| 597 |
BLOOD UREA INCREASED |
9 |
0.0005 |
| 598 |
MALNUTRITION |
6 |
0.0005 |
| 599 |
NEPHROPATHY |
5 |
0.0005 |
| 600 |
MIDDLE INSOMNIA |
10 |
0.0005 |
| 601 |
TUBULOINTERSTITIAL NEPHRITIS |
10 |
0.0005 |
| 602 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 603 |
ORAL CANDIDIASIS |
7 |
0.0005 |
| 604 |
LACRIMATION INCREASED |
16 |
0.0005 |
| 605 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
15 |
0.0005 |
| 606 |
GAIT DISTURBANCE |
101 |
0.0005 |
| 607 |
URINARY TRACT INFECTION |
90 |
0.0005 |
| 608 |
BLOOD URINE PRESENT |
10 |
0.0005 |
| 609 |
ILL-DEFINED DISORDER |
32 |
0.0005 |
| 610 |
PROTEINURIA |
10 |
0.0005 |
| 611 |
AORTIC ANEURYSM |
4 |
0.0005 |
| 612 |
INTENTIONAL PRODUCT MISUSE |
46 |
0.0005 |
| 613 |
ANGINA PECTORIS |
15 |
0.0005 |
| 614 |
DEVICE PHYSICAL PROPERTY ISSUE |
4 |
0.0005 |
| 615 |
EYE IRRITATION |
30 |
0.0005 |
| 616 |
SEROTONIN SYNDROME |
10 |
0.0005 |
| 617 |
HYPERSENSITIVITY |
96 |
0.0005 |
| 618 |
LIMB DISCOMFORT |
16 |
0.0005 |
| 619 |
VITAMIN D DEFICIENCY |
5 |
0.0005 |
| 620 |
SURGERY |
30 |
0.0005 |
| 621 |
PERIPHERAL COLDNESS |
7 |
0.0005 |
| 622 |
VISUAL IMPAIRMENT |
63 |
0.0005 |
| 623 |
KNEE OPERATION |
5 |
0.0005 |
| 624 |
HOSPICE CARE |
5 |
0.0005 |
| 625 |
GALLBLADDER DISORDER |
9 |
0.0005 |
| 626 |
TRANSIENT ISCHAEMIC ATTACK |
17 |
0.0005 |
| 627 |
ACCIDENT |
6 |
0.0005 |
| 628 |
GASTROENTERITIS VIRAL |
9 |
0.0005 |
| 629 |
HAEMATURIA |
17 |
0.0005 |
| 630 |
HEADACHE |
311 |
0.0005 |
| 631 |
FRUSTRATION TOLERANCE DECREASED |
4 |
0.0005 |
| 632 |
MUSCLE DISORDER |
4 |
0.0005 |
| 633 |
PRESYNCOPE |
12 |
0.0005 |
| 634 |
NASAL CONGESTION |
29 |
0.0005 |
| 635 |
PLEURAL EFFUSION |
30 |
0.0005 |
| 636 |
DRY THROAT |
5 |
0.0005 |
| 637 |
POST PROCEDURAL INFECTION |
4 |
0.0005 |
| 638 |
SNEEZING |
11 |
0.0005 |
| 639 |
EAR DISCOMFORT |
5 |
0.0005 |
| 640 |
RIB FRACTURE |
10 |
0.0005 |
| 641 |
OCULAR HYPERAEMIA |
23 |
0.0005 |
| 642 |
HYPERTHYROIDISM |
7 |
0.0005 |
| 643 |
CYST |
6 |
0.0005 |
| 644 |
AGEUSIA |
12 |
0.0005 |
| 645 |
LIP SWELLING |
16 |
0.0005 |
| 646 |
PETECHIAE |
5 |
0.0005 |
| 647 |
BONE DENSITY DECREASED |
15 |
0.0005 |
| 648 |
ATRIAL SEPTAL DEFECT |
4 |
0.0005 |
| 649 |
PNEUMONIA |
154 |
0.0005 |
| 650 |
BALANCE DISORDER |
41 |
0.0005 |
| 651 |
SCRATCH |
5 |
0.0005 |
| 652 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
16 |
0.0005 |
| 653 |
CARDIAC FAILURE |
38 |
0.0005 |
| 654 |
ABDOMINAL PAIN |
110 |
0.0005 |
| 655 |
CARDIOVASCULAR DISORDER |
12 |
0.0005 |
| 656 |
SKIN HAEMORRHAGE |
7 |
0.0005 |
| 657 |
FEELING JITTERY |
9 |
0.0005 |
| 658 |
RENAL DISORDER |
22 |
0.0005 |
| 659 |
FLUID RETENTION |
24 |
0.0005 |
| 660 |
HYPOPHAGIA |
12 |
0.0005 |
| 661 |
POST PROCEDURAL COMPLICATION |
9 |
0.0005 |
| 662 |
THROAT IRRITATION |
21 |
0.0005 |
| 663 |
BONE LOSS |
7 |
0.0005 |
| 664 |
PYREXIA |
161 |
0.0005 |
| 665 |
INJECTION SITE INDURATION |
6 |
0.0005 |
| 666 |
SKIN LACERATION |
5 |
0.0005 |
| 667 |
NODULE |
6 |
0.0005 |
| 668 |
SEPTIC SHOCK |
20 |
0.0005 |
| 669 |
INTERVERTEBRAL DISC PROTRUSION |
10 |
0.0005 |
| 670 |
FEELING HOT |
28 |
0.0005 |
| 671 |
PHARYNGEAL OEDEMA |
7 |
0.0005 |
| 672 |
MUSCULOSKELETAL CHEST PAIN |
7 |
0.0005 |
| 673 |
DENTAL CARIES |
5 |
0.0005 |
| 674 |
VIRAL INFECTION |
15 |
0.0005 |
| 675 |
FEELING ABNORMAL |
108 |
0.0005 |
| 676 |
DYSPNOEA |
255 |
0.0005 |
| 677 |
EYE HAEMORRHAGE |
6 |
0.0004 |
| 678 |
CHEST DISCOMFORT |
46 |
0.0004 |
| 679 |
BASAL CELL CARCINOMA |
7 |
0.0004 |
| 680 |
CYTOKINE RELEASE SYNDROME |
9 |
0.0004 |
| 681 |
DRUG INEFFECTIVE |
585 |
0.0004 |
| 682 |
PRODUCT USE IN UNAPPROVED INDICATION |
110 |
0.0004 |
| 683 |
EYE INFECTION |
5 |
0.0004 |
| 684 |
LEUKOCYTOSIS |
8 |
0.0004 |
| 685 |
NEUROPATHY PERIPHERAL |
42 |
0.0004 |
| 686 |
BODY TEMPERATURE INCREASED |
9 |
0.0004 |
| 687 |
DRY EYE |
22 |
0.0004 |
| 688 |
GINGIVAL BLEEDING |
6 |
0.0004 |
| 689 |
PAIN |
269 |
0.0004 |
| 690 |
METABOLIC ACIDOSIS |
14 |
0.0004 |
| 691 |
ACCIDENTAL OVERDOSE |
16 |
0.0004 |
| 692 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
31 |
0.0004 |
| 693 |
INCREASED TENDENCY TO BRUISE |
4 |
0.0004 |
| 694 |
GASTRIC HAEMORRHAGE |
5 |
0.0004 |
| 695 |
HAEMATEMESIS |
11 |
0.0004 |
| 696 |
INJECTION SITE MASS |
16 |
0.0004 |
| 697 |
INTERVERTEBRAL DISC DEGENERATION |
4 |
0.0004 |
| 698 |
ORAL DISCOMFORT |
6 |
0.0004 |
| 699 |
EYE SWELLING |
16 |
0.0004 |
| 700 |
DERMATITIS |
9 |
0.0004 |
| 701 |
DEVICE OCCLUSION |
6 |
0.0004 |
| 702 |
PARAESTHESIA |
67 |
0.0004 |
| 703 |
CARDIAC FAILURE CONGESTIVE |
34 |
0.0004 |
| 704 |
INFLUENZA |
47 |
0.0004 |
| 705 |
COUGH |
118 |
0.0004 |
| 706 |
MUSCULOSKELETAL DISORDER |
8 |
0.0004 |
| 707 |
RED BLOOD CELL COUNT DECREASED |
12 |
0.0004 |
| 708 |
URINARY RETENTION |
14 |
0.0004 |
| 709 |
WHITE BLOOD CELL COUNT INCREASED |
16 |
0.0004 |
| 710 |
PRURITUS GENERALISED |
9 |
0.0004 |
| 711 |
ANOSMIA |
6 |
0.0004 |
| 712 |
INJECTION SITE BRUISING |
33 |
0.0004 |
| 713 |
SEPSIS |
46 |
0.0004 |
| 714 |
CLOSTRIDIUM DIFFICILE INFECTION |
9 |
0.0004 |
| 715 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
7 |
0.0004 |
| 716 |
SMALL INTESTINAL OBSTRUCTION |
5 |
0.0004 |
| 717 |
HYPERCALCAEMIA |
5 |
0.0004 |
| 718 |
LIGAMENT SPRAIN |
4 |
0.0004 |
| 719 |
INABILITY TO AFFORD MEDICATION |
4 |
0.0004 |
| 720 |
COLITIS ULCERATIVE |
18 |
0.0004 |
| 721 |
UPPER LIMB FRACTURE |
8 |
0.0004 |
| 722 |
BRAIN INJURY |
4 |
0.0004 |
| 723 |
HAEMATOCHEZIA |
22 |
0.0004 |
| 724 |
ANXIETY |
113 |
0.0004 |
| 725 |
CELLULITIS |
20 |
0.0004 |
| 726 |
MALAISE |
174 |
0.0004 |
| 727 |
FALL |
132 |
0.0004 |
| 728 |
EMPHYSEMA |
4 |
0.0004 |
| 729 |
PRODUCT QUALITY ISSUE |
53 |
0.0004 |
| 730 |
DEHYDRATION |
52 |
0.0004 |
| 731 |
PRODUCT PREPARATION ERROR |
8 |
0.0004 |
| 732 |
EYE PRURITUS |
13 |
0.0004 |
| 733 |
TOOTHACHE |
7 |
0.0004 |
| 734 |
EYE DISCHARGE |
4 |
0.0004 |
| 735 |
SWELLING FACE |
25 |
0.0004 |
| 736 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
20 |
0.0004 |
| 737 |
ADVERSE REACTION |
5 |
0.0004 |
| 738 |
BLOOD PRESSURE FLUCTUATION |
9 |
0.0004 |
| 739 |
CARDIAC DISORDER |
35 |
0.0004 |
| 740 |
THROMBOSIS |
30 |
0.0004 |
| 741 |
HEREDITARY ANGIOEDEMA |
4 |
0.0004 |
| 742 |
SKIN CANCER |
8 |
0.0004 |
| 743 |
INTESTINAL OBSTRUCTION |
14 |
0.0004 |
| 744 |
BLOOD SODIUM DECREASED |
7 |
0.0004 |
| 745 |
HYPOGLYCAEMIA |
18 |
0.0004 |
| 746 |
DISTURBANCE IN ATTENTION |
20 |
0.0004 |
| 747 |
TINNITUS |
17 |
0.0004 |
| 748 |
FRACTURE |
7 |
0.0004 |
| 749 |
AMNESIA |
24 |
0.0004 |
| 750 |
PULMONARY THROMBOSIS |
4 |
0.0004 |
| 751 |
LETHARGY |
21 |
0.0004 |
| 752 |
ANAEMIA |
69 |
0.0004 |
| 753 |
FUNGAL INFECTION |
12 |
0.0004 |
| 754 |
TRANSAMINASES INCREASED |
8 |
0.0004 |
| 755 |
FEELING COLD |
10 |
0.0004 |
| 756 |
HAEMORRHOIDS |
7 |
0.0004 |
| 757 |
INJECTION SITE RASH |
11 |
0.0004 |
| 758 |
SKIN FISSURES |
7 |
0.0004 |
| 759 |
SOMNOLENCE |
72 |
0.0004 |
| 760 |
CARPAL TUNNEL SYNDROME |
5 |
0.0004 |
| 761 |
RASH PAPULAR |
8 |
0.0004 |
| 762 |
MYOCARDIAL ISCHAEMIA |
4 |
0.0004 |
| 763 |
DERMATITIS CONTACT |
4 |
0.0004 |
| 764 |
ERECTILE DYSFUNCTION |
9 |
0.0004 |
| 765 |
SUBDURAL HAEMATOMA |
5 |
0.0003 |
| 766 |
IMPAIRED QUALITY OF LIFE |
5 |
0.0003 |
| 767 |
RESPIRATORY TRACT INFECTION |
9 |
0.0003 |
| 768 |
ORTHOSTATIC HYPOTENSION |
6 |
0.0003 |
| 769 |
HYPOKINESIA |
5 |
0.0003 |
| 770 |
ELECTROLYTE IMBALANCE |
4 |
0.0003 |
| 771 |
SKIN EXFOLIATION |
29 |
0.0003 |
| 772 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
9 |
0.0003 |
| 773 |
INJECTION SITE PRURITUS |
23 |
0.0003 |
| 774 |
GASTROENTERITIS |
5 |
0.0003 |
| 775 |
MEDICATION ERROR |
19 |
0.0003 |
| 776 |
HYPERHIDROSIS |
44 |
0.0003 |
| 777 |
COLD SWEAT |
6 |
0.0003 |
| 778 |
ASCITES |
10 |
0.0003 |
| 779 |
HYPOTENSION |
68 |
0.0003 |
| 780 |
DIABETES MELLITUS INADEQUATE CONTROL |
6 |
0.0003 |
| 781 |
ARRHYTHMIA |
16 |
0.0003 |
| 782 |
ATAXIA |
4 |
0.0003 |
| 783 |
LOSS OF CONSCIOUSNESS |
43 |
0.0003 |
| 784 |
RASH ERYTHEMATOUS |
16 |
0.0003 |
| 785 |
THROAT TIGHTNESS |
9 |
0.0003 |
| 786 |
TREMOR |
55 |
0.0003 |
| 787 |
PELVIC PAIN |
6 |
0.0003 |
| 788 |
PSORIASIS |
43 |
0.0003 |
| 789 |
INCORRECT DOSE ADMINISTERED |
75 |
0.0003 |
| 790 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
6 |
0.0003 |
| 791 |
SKIN DISCOLOURATION |
15 |
0.0003 |
| 792 |
INJECTION SITE URTICARIA |
8 |
0.0003 |
| 793 |
MUSCLE SPASTICITY |
4 |
0.0003 |
| 794 |
DEPRESSION |
74 |
0.0003 |
| 795 |
ECZEMA |
17 |
0.0003 |
| 796 |
FLUSHING |
33 |
0.0003 |
| 797 |
BONE PAIN |
19 |
0.0003 |
| 798 |
ALTERED STATE OF CONSCIOUSNESS |
7 |
0.0003 |
| 799 |
GASTROINTESTINAL HAEMORRHAGE |
27 |
0.0003 |
| 800 |
ANKLE FRACTURE |
5 |
0.0003 |
| 801 |
TENDONITIS |
5 |
0.0003 |
| 802 |
FEMUR FRACTURE |
10 |
0.0003 |
| 803 |
HAEMOPTYSIS |
9 |
0.0003 |
| 804 |
PHARYNGITIS |
4 |
0.0003 |
| 805 |
EJECTION FRACTION DECREASED |
5 |
0.0003 |
| 806 |
HAIR COLOUR CHANGES |
4 |
0.0003 |
| 807 |
HAEMOGLOBIN DECREASED |
33 |
0.0003 |
| 808 |
THERAPY PARTIAL RESPONDER |
5 |
0.0003 |
| 809 |
OXYGEN SATURATION DECREASED |
18 |
0.0003 |
| 810 |
DERMATITIS ALLERGIC |
4 |
0.0003 |
| 811 |
COLITIS |
12 |
0.0003 |
| 812 |
MUSCLE ATROPHY |
4 |
0.0003 |
| 813 |
PULMONARY EMBOLISM |
30 |
0.0003 |
| 814 |
CHILLS |
37 |
0.0003 |
| 815 |
DISEASE RECURRENCE |
15 |
0.0003 |
| 816 |
INJECTION SITE IRRITATION |
4 |
0.0003 |
| 817 |
PRODUCTIVE COUGH |
15 |
0.0003 |
| 818 |
EMOTIONAL DISTRESS |
38 |
0.0003 |
| 819 |
BURNING SENSATION |
22 |
0.0003 |
| 820 |
HEART RATE DECREASED |
11 |
0.0003 |
| 821 |
HYPOXIA |
11 |
0.0003 |
| 822 |
DEVICE ISSUE |
28 |
0.0003 |
| 823 |
RHABDOMYOLYSIS |
13 |
0.0003 |
| 824 |
SENSORY DISTURBANCE |
5 |
0.0003 |
| 825 |
SYNCOPE |
31 |
0.0003 |
| 826 |
DEEP VEIN THROMBOSIS |
20 |
0.0003 |
| 827 |
NERVOUSNESS |
16 |
0.0003 |
| 828 |
VISION BLURRED |
42 |
0.0003 |
| 829 |
KIDNEY INFECTION |
6 |
0.0003 |
| 830 |
CHOLELITHIASIS |
10 |
0.0003 |
| 831 |
METASTASES TO BONE |
5 |
0.0003 |
| 832 |
OSTEONECROSIS |
10 |
0.0003 |
| 833 |
INCORRECT PRODUCT STORAGE |
4 |
0.0003 |
| 834 |
BEDRIDDEN |
4 |
0.0003 |
| 835 |
VENTRICULAR TACHYCARDIA |
5 |
0.0003 |
| 836 |
DEPRESSED MOOD |
16 |
0.0003 |
| 837 |
DYSMENORRHOEA |
4 |
0.0003 |
| 838 |
SKIN DISORDER |
10 |
0.0003 |
| 839 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0003 |
| 840 |
BLOOD BILIRUBIN INCREASED |
8 |
0.0003 |
| 841 |
MOOD ALTERED |
8 |
0.0003 |
| 842 |
INJECTION SITE WARMTH |
6 |
0.0003 |
| 843 |
SWOLLEN TONGUE |
9 |
0.0003 |
| 844 |
MENTAL STATUS CHANGES |
8 |
0.0003 |
| 845 |
DEVICE DIFFICULT TO USE |
19 |
0.0003 |
| 846 |
HAEMORRHAGE |
30 |
0.0003 |
| 847 |
APHONIA |
4 |
0.0003 |
| 848 |
IRRITABILITY |
17 |
0.0003 |
| 849 |
HEAD DISCOMFORT |
5 |
0.0003 |
| 850 |
DIALYSIS |
4 |
0.0003 |
| 851 |
EATING DISORDER |
6 |
0.0003 |
| 852 |
DEATH |
242 |
0.0003 |
| 853 |
IMPAIRED WORK ABILITY |
6 |
0.0003 |
| 854 |
INFLUENZA LIKE ILLNESS |
23 |
0.0003 |
| 855 |
PARALYSIS |
4 |
0.0003 |
| 856 |
HYPERSOMNIA |
8 |
0.0003 |
| 857 |
HYPOACUSIS |
12 |
0.0003 |
| 858 |
HALLUCINATION |
21 |
0.0003 |
| 859 |
HYPERGLYCAEMIA |
10 |
0.0003 |
| 860 |
HEPATITIS |
7 |
0.0003 |
| 861 |
DYSURIA |
10 |
0.0003 |
| 862 |
URINARY INCONTINENCE |
8 |
0.0003 |
| 863 |
NEUTROPHIL COUNT DECREASED |
11 |
0.0003 |
| 864 |
DIPLOPIA |
7 |
0.0003 |
| 865 |
PULMONARY OEDEMA |
12 |
0.0003 |
| 866 |
ORAL PAIN |
6 |
0.0003 |
| 867 |
DYSPNOEA EXERTIONAL |
10 |
0.0003 |
| 868 |
APHASIA |
8 |
0.0003 |
| 869 |
INJECTION SITE PAIN |
81 |
0.0003 |
| 870 |
PRODUCT SUBSTITUTION ISSUE |
15 |
0.0003 |
| 871 |
NIGHTMARE |
9 |
0.0003 |
| 872 |
TACHYCARDIA |
23 |
0.0003 |
| 873 |
LYMPHOMA |
4 |
0.0003 |
| 874 |
RASH MACULAR |
9 |
0.0003 |
| 875 |
BLOOD PRESSURE SYSTOLIC INCREASED |
5 |
0.0003 |
| 876 |
PLASMA CELL MYELOMA |
10 |
0.0003 |
| 877 |
DEVICE MALFUNCTION |
18 |
0.0003 |
| 878 |
DEVICE DELIVERY SYSTEM ISSUE |
7 |
0.0003 |
| 879 |
LYMPHADENOPATHY |
9 |
0.0003 |
| 880 |
DISORIENTATION |
10 |
0.0003 |
| 881 |
PNEUMOTHORAX |
4 |
0.0003 |
| 882 |
PREMATURE DELIVERY |
4 |
0.0003 |
| 883 |
SPINAL FRACTURE |
5 |
0.0002 |
| 884 |
FULL BLOOD COUNT DECREASED |
5 |
0.0002 |
| 885 |
INJECTION SITE SWELLING |
19 |
0.0002 |
| 886 |
EXTRA DOSE ADMINISTERED |
10 |
0.0002 |
| 887 |
ENCEPHALOPATHY |
6 |
0.0002 |
| 888 |
STAPHYLOCOCCAL INFECTION |
8 |
0.0002 |
| 889 |
OSTEONECROSIS OF JAW |
6 |
0.0002 |
| 890 |
INJECTION SITE ERYTHEMA |
30 |
0.0002 |
| 891 |
TOOTH LOSS |
5 |
0.0002 |
| 892 |
CYTOMEGALOVIRUS INFECTION |
4 |
0.0002 |
| 893 |
NEEDLE ISSUE |
7 |
0.0002 |
| 894 |
PULMONARY HYPERTENSION |
5 |
0.0002 |
| 895 |
ERYTHEMA |
49 |
0.0002 |
| 896 |
UNEVALUABLE EVENT |
18 |
0.0002 |
| 897 |
ANGER |
8 |
0.0002 |
| 898 |
UNRESPONSIVE TO STIMULI |
6 |
0.0002 |
| 899 |
DRY SKIN |
31 |
0.0002 |
| 900 |
VERTIGO |
14 |
0.0002 |
| 901 |
METASTASES TO LIVER |
4 |
0.0002 |
| 902 |
BRADYCARDIA |
12 |
0.0002 |
| 903 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
4 |
0.0002 |
| 904 |
DRUG ERUPTION |
4 |
0.0002 |
| 905 |
TOOTH DISORDER |
5 |
0.0002 |
| 906 |
NEOPLASM MALIGNANT |
15 |
0.0002 |
| 907 |
CEREBRAL HAEMORRHAGE |
8 |
0.0002 |
| 908 |
DYSKINESIA |
9 |
0.0002 |
| 909 |
HEAD INJURY |
7 |
0.0002 |
| 910 |
OSTEOMYELITIS |
4 |
0.0002 |
| 911 |
INJECTION SITE REACTION |
15 |
0.0002 |
| 912 |
LACTIC ACIDOSIS |
7 |
0.0002 |
| 913 |
MALIGNANT NEOPLASM PROGRESSION |
22 |
0.0002 |
| 914 |
COGNITIVE DISORDER |
10 |
0.0002 |
| 915 |
ACCIDENTAL EXPOSURE TO PRODUCT |
22 |
0.0002 |
| 916 |
HYPOCALCAEMIA |
4 |
0.0002 |
| 917 |
DEVICE LEAKAGE |
9 |
0.0002 |
| 918 |
HAEMATOCRIT DECREASED |
4 |
0.0002 |
| 919 |
DEVICE USE ERROR |
7 |
0.0002 |
| 920 |
INJECTION SITE HAEMORRHAGE |
16 |
0.0002 |
| 921 |
GASTRIC CANCER |
5 |
0.0002 |
| 922 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
14 |
0.0002 |
| 923 |
HYPONATRAEMIA |
11 |
0.0002 |
| 924 |
SKIN ULCER |
5 |
0.0002 |
| 925 |
HAEMATOMA |
5 |
0.0002 |
| 926 |
EXPOSURE VIA SKIN CONTACT |
5 |
0.0002 |
| 927 |
CARDIO-RESPIRATORY ARREST |
8 |
0.0002 |
| 928 |
DEAFNESS |
5 |
0.0002 |
| 929 |
MOUTH ULCERATION |
4 |
0.0002 |
| 930 |
NO ADVERSE EVENT |
34 |
0.0002 |
| 931 |
HIP FRACTURE |
6 |
0.0002 |
| 932 |
FEAR |
5 |
0.0002 |
| 933 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
4 |
0.0002 |
| 934 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 935 |
SKIN LESION |
5 |
0.0002 |
| 936 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
10 |
0.0002 |
| 937 |
MELAENA |
4 |
0.0002 |
| 938 |
DRUG DOSE OMISSION |
30 |
0.0002 |
| 939 |
RESPIRATORY ARREST |
5 |
0.0002 |
| 940 |
ABNORMAL DREAMS |
5 |
0.0002 |
| 941 |
THERAPEUTIC RESPONSE SHORTENED |
6 |
0.0002 |
| 942 |
PROCEDURAL PAIN |
5 |
0.0002 |
| 943 |
PANCYTOPENIA |
10 |
0.0002 |
| 944 |
DEMENTIA |
5 |
0.0002 |
| 945 |
FOETAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 946 |
LIVER FUNCTION TEST ABNORMAL |
5 |
0.0002 |
| 947 |
BREAST CANCER |
16 |
0.0002 |
| 948 |
DERMATITIS ATOPIC |
9 |
0.0002 |
| 949 |
PSYCHOTIC DISORDER |
5 |
0.0002 |
| 950 |
PANIC ATTACK |
6 |
0.0002 |
| 951 |
RESPIRATORY FAILURE |
12 |
0.0002 |
| 952 |
LEUKOPENIA |
8 |
0.0002 |
| 953 |
CARDIAC ARREST |
13 |
0.0002 |
| 954 |
MOOD SWINGS |
5 |
0.0002 |
| 955 |
SEIZURE |
18 |
0.0002 |
| 956 |
ANAPHYLACTIC SHOCK |
4 |
0.0002 |
| 957 |
SPEECH DISORDER |
8 |
0.0002 |
| 958 |
GASTRITIS |
4 |
0.0002 |
| 959 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
6 |
0.0002 |
| 960 |
PROSTATE CANCER |
12 |
0.0001 |
| 961 |
JAUNDICE |
4 |
0.0001 |
| 962 |
PAIN OF SKIN |
4 |
0.0001 |
| 963 |
NEUTROPENIA |
20 |
0.0001 |
| 964 |
PANCREATIC CARCINOMA |
4 |
0.0001 |
| 965 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
5 |
0.0001 |
| 966 |
RESTLESSNESS |
5 |
0.0001 |
| 967 |
BLADDER CANCER |
8 |
0.0001 |
| 968 |
ACNE |
10 |
0.0001 |
| 969 |
MULTIPLE SCLEROSIS RELAPSE |
9 |
0.0001 |
| 970 |
EMOTIONAL DISORDER |
4 |
0.0001 |
| 971 |
DRUG DOSE OMISSION BY DEVICE |
10 |
0.0001 |
| 972 |
ABNORMAL BEHAVIOUR |
5 |
0.0001 |
| 973 |
RENAL CANCER |
6 |
0.0001 |
| 974 |
MULTIPLE SCLEROSIS |
6 |
0.0001 |
| 975 |
GASTRIC DISORDER |
4 |
0.0001 |
| 976 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 977 |
INTENTIONAL OVERDOSE |
7 |
0.0001 |
| 978 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
5 |
0.0001 |
| 979 |
DYSARTHRIA |
4 |
0.0001 |
| 980 |
COMA |
5 |
0.0001 |
| 981 |
AGGRESSION |
5 |
0.0001 |
| 982 |
DEVICE BREAKAGE |
4 |
0.0001 |
| 983 |
LUNG NEOPLASM MALIGNANT |
4 |
0.0001 |
| 984 |
ANGIOEDEMA |
4 |
0.0001 |
| 985 |
THROMBOCYTOPENIA |
10 |
0.0001 |
| 986 |
DISEASE PROGRESSION |
10 |
0.0001 |
| 987 |
SUICIDAL IDEATION |
7 |
0.0001 |
| 988 |
OVERDOSE |
13 |
0.0001 |
| 989 |
DRUG WITHDRAWAL SYNDROME |
5 |
0.0001 |
| 990 |
AGITATION |
4 |
0.0001 |
| 991 |
TOXICITY TO VARIOUS AGENTS |
5 |
0.0000 |